<DOC>
	<DOCNO>NCT00002095</DOCNO>
	<brief_summary>To evaluate efficacy oral ganciclovir prevent progression cytomegalovirus ( CMV ) disease ( e.g. , CMV retinitis , gastrointestinal CMV disease ) CMV-infected people HIV infection CD4 lymphocyte count &lt; = 100 cells/mm3 . To evaluate efficacy drug reduce morbidity associate coinfection CMV HIV .</brief_summary>
	<brief_title>A Randomized , Double-Blind Study Efficacy Safety Oral Ganciclovir Prevention CMV Disease People Infected With Human Immunodeficiency Virus</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Topical ophthalmic nucleoside analog . Patients must : Confirmation HIV infection . Documented CMV infection . No past present CMV disease ( e.g. , retinitis , colitis , esophagitis ) . Adequate visualization retina eye ophthalmologist . CD4 count &lt; = 50 cells/mm3 ( patient WITHOUT history AIDSdefining opportunistic infection chronic gynecologic infection ) OR CD4 count &lt; = 100 cells/mm3 ( patient WITH history AIDSdefining opportunistic infection chronic gynecologic infection ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Presence gastrointestinal disease symptom control medication ( e.g. , persistent nausea , abdominal pain persistent diarrhea within past 4 week controllable medication ) . Inability comply protocol . Concurrent Medication : Excluded : The following nucleoside analog : IV ganciclovir , IV acyclovir 2 week total duration , oral acyclovir dos &gt; 1000 mg/day , vidarabine , amantadine hydrochloride , cytarabine , idoxuridine . FIAU , FIAC , foscarnet , CMV hyperimmune globulin , IV immune globulin , CMV monoclonal antibody , HPMPC . Imipenemcilastatin ( Primaxin ) . Patients follow prior condition exclude : History hypersensitivity acyclovir . Prior Medication : Excluded within past 60 day : Ganciclovir , foscarnet , FIAC , FIAU , CMV hyperimmune globulin , CMV monoclonal antibody , HPMPC .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1993</verification_date>
	<keyword>Ganciclovir</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>